David Meeker

David P.
Meeker is Chairman, President & Chief Executive Officer at Rhythm Pharmaceuticals, Inc. since 2020, Chairman at Trevi Therapeutics, Inc. since 2017, Non-Executive Chairman at Pharvaris NV since 2021, Chairman at Pharvaris GmbH since 2021, Director at Biotechnology Innovation Organization, Director at New England Healthcare Institute, Director at Prize4Life, Inc., Independent Director at Turmeric Acquisition Corp., and Independent Non-Executive Director at Kardigan, Inc. since 2024.
Former roles include President, Chief Executive Officer & Director at Genzyme Corp.
from 2011 to 2017, President & Chief Executive Officer at Genzyme SAS from 2011 to 2017, President, Chief Executive Officer & Director at KSQ Therapeutics, Inc. from 2017 to 2020, Independent Director at Savient Pharmaceuticals, Inc. from 2013 to 2014, Director at Penwest Pharmaceuticals Co. from 2007 to 2010, Independent Director at MyoKardia, Inc. from 2017 to 2020, Director-Pulmonary Critical Care Fellowship at The Cleveland Clinic Foundation, Assistant Professor at The Ohio State University, Executive Vice President at Sanofi from 2012 to 2017, and Senior Vice President at Sanofi BV in 2003.
Education includes a doctorate from the University of Vermont College of Medicine.